The European-funded research project, Psych-STRATA, officially kicked off in Münster, Germany, on the 20th of October. The five-year project brings together 26 partners from 12 countries across the globe to develop personalised medicine in mental health. Psych-STRATA aims to reduce the trial-and-error approach to treatment and identify patients at risk for treatment resistance early in the condition.
The partners, assembled to prepare for the next steps in this ambitious project. Psych-STRATA will focus on combining biological, digital mental health, and clinical data to create evidence-based strategies for effective treatment. By leveraging an unparalleled collection of data, including therapy response and outcomes across three relevant mental disorders, the project seeks to enable evidence-based identification of patients at risk for treatment resistance (TR) early in the disease.
The project, coordinated by the University of Münster, represents a significant step forward in personalized medicine and mental health treatment, with the potential to improve outcomes and quality of life for countless patients. As the project progresses, the international collaboration of partners will work together to pave the way for a future of customized, targeted mental health care.